We are live on ! Find out more
IRON icon

Disc Medicine

62 hedge funds and large institutions have $93.8M invested in Disc Medicine in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

343% more capital inflows, than outflows

Capital inflows: $27.1M | Capital outflows: $6.13M

246% more call options, than puts

Call options by funds: $211K | Put options by funds: $61K

15.38% more ownership

Funds ownership: 59.39% → 74.77% (+15%)

0% more funds holding

Funds holding: 62 → 62 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

11% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 18

Holders
62
Holders Change
–
Holders Change %
0%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
16
Reduced
18
Closed
13
Calls
$211​K
Puts
$61​K
Net Calls
+$150​K
Net Calls Change
-⁠$1.46​M

IRON Hedge Fund Activity: Q4 2021 in Review

62 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q4 2021, worth a combined $93.8M — down 9.4% from $103M a quarter earlier.

Fund positioning in IRON was balanced in Q4 2021: 13 funds opened new positions, 13 closed out, 16 added to existing stakes and 18 trimmed.

The largest buyer was Suvretta Capital Management, adding an estimated $766K. The largest seller was Vanguard Group, cutting an estimated $1.55M.

  • 62 institutional investors held Disc Medicine (IRON) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $93.8M of Disc Medicine stock for Q4 2021, down 9.4% quarter-over-quarter.
  • 13 funds opened new Disc Medicine positions in Q4 2021 and 13 closed out, a net change of 0 holders.
  • The largest Disc Medicine buyer in Q4 2021 was Suvretta Capital Management, an estimated $766K added.
  • The largest Disc Medicine seller in Q4 2021 was Vanguard Group, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2021.